These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37364397)
1. ZLDI-8 suppresses angiogenesis and vasculogenic mimicry in drug-resistant NSCLC in vitro and in vivo. Lu H; Wu C; Jiang XW; Zhao Q Lung Cancer; 2023 Aug; 182():107279. PubMed ID: 37364397 [TBL] [Abstract][Full Text] [Related]
2. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer. Zang M; Hu L; Zhang B; Zhu Z; Li J; Zhu Z; Yan M; Liu B Biochem Biophys Res Commun; 2017 Aug; 490(3):913-919. PubMed ID: 28655612 [TBL] [Abstract][Full Text] [Related]
3. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo. Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576 [TBL] [Abstract][Full Text] [Related]
4. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer. Fan X; Huang J; Hu B; Zhou J; Chen L J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607 [TBL] [Abstract][Full Text] [Related]
5. The anti-angiogenic and anti-vasculogenic mimicry effects of GN25 in endothelial and glioma cells. Wen ZH; Chang L; Yang SN; Yu CL; Tung FY; Kuo HM; Lu IC; Wu CY; Shih PC; Chen WF; Chen NF Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119799. PubMed ID: 39043304 [TBL] [Abstract][Full Text] [Related]
6. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways. Li X; Wang X; Ye H; Peng A; Chen L Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678 [TBL] [Abstract][Full Text] [Related]
7. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma Chen YF; Wu S; Li X; Chen M; Liao HF Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596 [TBL] [Abstract][Full Text] [Related]
8. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449 [TBL] [Abstract][Full Text] [Related]
9. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms. Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974 [TBL] [Abstract][Full Text] [Related]
10. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis. Han L; Wang JN; Cao XQ; Sun CX; Du X Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906 [TBL] [Abstract][Full Text] [Related]
11. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway. Shi J; Lu Y; Wei P J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240 [TBL] [Abstract][Full Text] [Related]
12. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling. Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103 [TBL] [Abstract][Full Text] [Related]
13. The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancer. Wang B; Yu W; Guo J; Jiang X; Lu W; Liu M; Pang X J Pharmacol Exp Ther; 2015 Jan; 352(1):129-38. PubMed ID: 25352499 [TBL] [Abstract][Full Text] [Related]
14. Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway. Cheng X; Wang F; Qiao Y; Chen T; Fan L; Shen X; Yu D; Huang Y; Wei M Chem Biol Interact; 2023 Jan; 370():110295. PubMed ID: 36470525 [TBL] [Abstract][Full Text] [Related]
15. PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers. Zhang Y; Wang X; Li A; Guan Y; Shen P; Ni Y; Han X J Pharmacol Sci; 2022 Oct; 150(2):56-66. PubMed ID: 36055752 [TBL] [Abstract][Full Text] [Related]
16. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells. Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133 [TBL] [Abstract][Full Text] [Related]
17. RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply. Kong L; Cai FY; Yao XM; Jing M; Fu M; Liu JJ; He SY; Zhang L; Liu XZ; Ju RJ; Li XT Cancer Sci; 2020 Feb; 111(2):621-636. PubMed ID: 31777993 [TBL] [Abstract][Full Text] [Related]
18. DHPAC, a novel microtubule depolymerizing agent, suppresses angiogenesis and vasculogenic mimicry formation of human non-small cell lung cancer. Gong FL; Wang L; Yu LG; Dang YF; Jiang XN; Zhao L; Guo XL J Cell Biochem; 2020 Dec; 121(12):4756-4771. PubMed ID: 32056279 [TBL] [Abstract][Full Text] [Related]
19. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171 [TBL] [Abstract][Full Text] [Related]
20. The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma. Pulford E; McEvoy J; Hocking A; Prabhakaran S; Griggs K; Klebe S Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]